help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-0109
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorgan, J. F.
Right arrow Articles by Schatzkin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorgan, J. F.
Right arrow Articles by Schatzkin, A.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Male Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 10 3992-3996
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

Diet and Sex Hormones in Boys: Findings from the Dietary Intervention Study in Children

Joanne F. Dorgan, Robert P. McMahon, Lisa Aronson Friedman, Linda Van Horn, Linda G. Snetselaar, Peter O. Kwiterovich, Jr., Ronald M. Lauer, Norman L. Lasser, Victor J. Stevens, Alan Robson, Susan F. Cooper, D. Walt Chandler, Frank A. Franklin, Bruce A. Barton, Blossom H. Patterson, Philip R. Taylor and Arthur Schatzkin

Fox Chase Cancer Center (J.F.D.), Philadelphia, Pennsylvania 19111; Maryland Psychiatric Research Center (R.P.M.), University of Maryland Baltimore, Baltimore, Maryland 21228; Maryland Medical Research Institute (B.A.B., L.A.F.), Baltimore, Maryland 21210; Northwestern University Medical School (L.V.H.), Chicago, Illinois 60611; University of Iowa (L.G.S., R.M.L.), Iowa City, Iowa 52242; Johns Hopkins University (P.O.K.), Baltimore, Maryland 21205; New Jersey Medical School (N.L.L.), Newark, New Jersey 07107; Kaiser Permanente Center for Health Research (V.J.S.), Portland, Oregon 97227; Children’s Hospital (A.R.), New Orleans, Louisiana 70118; Office of Operations, Program Planning, and Scientific Information (S.F.C.), National Institute of Allergy and Infectious Diseases, and Divisions of Cancer Prevention (B.H.P.) and Cancer Epidemiology and Genetics (P.R.T., A.S.), National Cancer Institute, Bethesda, Maryland 20892; Esoterix Endocrinology, Inc. (D.W.C.), Calabasas Hills, California 91301; and Children’s Hospital of Alabama (F.A.F.), Birmingham, Alabama 35233

Address all correspondence and requests for reprints to: Dr. Joanne Dorgan, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111. E-mail: joanne.dorgan{at}fccc.edu.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Context: Diet reportedly alters serum sex hormone concentrations in adults, but little is known about the influence of diet during puberty on these hormones.

Objective: We aimed to determine whether an intervention to lower fat intake during adolescence alters serum sex hormone concentrations and progression through puberty.

Design: In 1990–1997, we conducted an ancillary study to the Dietary Intervention Study in Children, a multicenter, randomized, controlled clinical trial to test the safety and efficacy of a cholesterol-lowering dietary intervention in children.

Participants: Healthy, prepubertal, 8 to 10 yr olds with elevated low-density lipoprotein cholesterol were randomized to usual care or a behavioral intervention. Of 362 randomized Dietary Intervention Study in Children boys, 354 participated in the ancillary study. Eighty-four percent of boys attended last visits when their median time on trial was 7.1 yr.

Intervention: The behavioral intervention continued throughout the duration of the trial and promoted a diet with 28% energy from total fat, less than 8% from saturated fat, 9% or less from polyunsaturated fat, and less than 75 mg cholesterol per 1000 kcal.

Outcome Measures: The main outcome measure for boys formulated before study initiation was non-SHBG bound testosterone concentration. Secondary outcomes included serum total testosterone, dihydrotestosterone, androstenedione, estradiol, estrone, SHBG, and Tanner stage.

Results: There were no significant treatment group differences in boys’ serum hormone levels, SHBG, or Tanner stages at any individual visit or over the course of the trial when evaluated by longitudinal models.

Conclusion: Modest reductions in total fat, saturated fat, and possibly energy intake do not alter progression through puberty or serum sex hormone concentrations in adolescent boys.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
CONSIDERABLE INTEREST HAS recently focused on early life exposures and chronic diseases in adulthood. Childhood and adolescent diet could influence adult health via effects on metabolism, body composition, or possibly eating habits. Dietary fat has been reported to alter serum sex hormone concentrations in adult men (1, 2, 3, 4) and women (5), but little is known about the influence of diet during puberty on these hormones. We conducted a study ancillary to the Dietary Intervention Study in Children (DISC) to determine whether a dietary intervention to lower fat intake affects progression through puberty and serum estrogen and androgen levels in girls and boys. Results for girls were reported previously (6); here we report results for boys.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
DISC was a multicenter, randomized, controlled clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI) to test the safety and efficacy of a dietary intervention to reduce serum low-density lipoprotein cholesterol (LDL-C) in children with elevated LDL-C. Design and results of DISC have been described (7, 8, 9). Briefly, between 1988 and 1990, 663 children ages 8 to 10 yr with elevated LDL-C were randomly assigned to a dietary intervention to reduce fat intake or usual care at one of six DISC clinical centers. In 1990 the National Cancer Institute initiated the DISC Hormone Ancillary Study (HAS) to assess the effect of the intervention on serum sex hormones during adolescence. The initial DISC protocol was designed for 3 yr and was subsequently extended with planned intervention and follow-up of all participants until 18 yr of age. However, DISC was terminated in 1997 when participants’ ages averaged 16.7 yr because treatment groups did not differ significantly on LDL-C after yr 3 follow-up visits (9). Assent was obtained from DISC participants, and written informed consent was obtained from their parents or guardians before randomization and again when the study was extended. The DISC protocol and HAS were approved by institutional review boards at all participating centers, and a NHLBI-appointed independent data and safety monitoring committee provided oversight.

DISC recruited 362 boys through schools, health maintenance organizations, and pediatric practices. Boys were eligible if they were 8.6–10.8 yr old, had a serum LDL-C level in the 80th to 98th percentiles, had no major illness, were not taking medications that affect lipid levels or growth, were at least in the fifth percentile for height and the fifth to 90th percentiles for weight for height, were Tanner stage 1 for genital and pubic hair development, and had normal psychosocial and cognitive development. Boys were not eligible if they or their family members were already following a low-fat diet, a parent had a history of early heart disease, the family planned to move within 3 yr, or there were known behavioral problems.

Three hundred fifty-four DISC boys participated in the HAS at one or more visits. Because the HAS was initiated after DISC commenced, we had no baseline and yr 1 blood samples, respectively, for 261 and 122 of the boys in our study. Except where explicitly stated, results presented here pertain to DISC boys who participated in the HAS. Eighty-four percent were Caucasian, 11% were African-American, and 5% were other races. Their median duration on study at the last visit was 7.1 yr (range 6.5–9.1 yr).

DISC dietary goals were to limit total fat intake to 28% of calories with less than 8% of calories from saturated fat and 9% or less of calories from polyunsaturated fat. Cholesterol intake was limited to 75 mg per 1000 calories and was not to exceed 150 mg/d. Dietary fiber intake was encouraged. Boys in the intervention group and their families attended individual and group sessions that were designed to teach them how to achieve the DISC dietary goals and that continued throughout the trial (10, 11). Boys in the usual care group and their families were given American Heart Association nutrition education materials that are generally available to the public. None of the boys in the intervention or usual care groups took cholesterol-lowering medications during DISC.

Data were collected at baseline and annually thereafter by trained staff who were blinded to the participants’ treatment assignments. Each participant underwent a brief physical examination that included assessment of sexual maturation by testicular volume and Tanner stage until boys reached Tanner stage 5. Testicular volume was measured using Prader orchidometer beads, and Tanner stages were assessed in comparison with photographs to ensure standardization across clinics.

Three nonconsecutive 24-h dietary recalls were collected over a 2-wk period at baseline, yr 1, yr 3, yr 5, and last visits (12, 13). Nutrient analyses were performed by the Nutrition Coordinating Center, University of Minnesota (Minneapolis, MN). Data from the three recalls at each visit were averaged to estimate mean nutrient intake.

A single blood sample was collected by venipuncture in the morning after an overnight fast at baseline, yr 1, yr 3, yr 5, and last visits. Serum was separated by centrifugation after the blood sample was kept at room temperature for at least 45 min to allow complete clotting. Serum was then aliquoted and stored in glass vials at –80 C.

Hormone assays were performed by Esoterix Endocrinology, Inc. (Calabasas Hills, CA). Steroid hormones were measured by RIA, and SHBG was measured by an immunoradiometric assay (14, 15). The concentration of non-SHBG-bound testosterone, which was the main outcome for boys, was calculated as the product of the total testosterone concentration and the percent non-SHBG-bound testosterone, which was measured by ammonium sulfate precipitation (15).

All analyses were performed by randomized treatment assignment. Serum hormone concentrations were loge transformed before analyses. Analysis of covariance was used to calculate mean hormone concentrations at each visit adjusted for age and race (white, nonwhite) and test statistical significance of treatment group differences. Because randomization in DISC was almost complete when the ancillary study was initiated, few boys had baseline values and comparisons at follow-up visits were not adjusted for baseline values. However, when available, baseline values were included in longitudinal analyses that were performed to evaluate changes over time on trial and implemented using mixed linear models (SAS Proc Mixed; SAS Institute, Inc., Cary, NC). Time on trial was centered on its mean before modeling. Fixed effects specified in models were treatment group, race, baseline age, and a cubic function of time on trial. Random effects included subject intercepts and a cubic function of time on trial. To determine whether slopes of change in hormone concentrations over time differed for intervention and usual care group boys independently of any age-related changes, interaction terms were included in models for treatment group by time on trial and for baseline age by time on trial. No imputations were performed for missing data. All tests of statistical significance were two sided. Statistical analyses were conducted using SAS (version 9.1; SAS Institute).


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Table 1Go summarizes characteristics of the boys who participated in the DISC HAS. The mean ages, heights, weights, and body mass index Z-scores were similar for boys in the intervention and usual care groups at each visit. Intervention boys reported consuming statistically significantly less energy as total fat and saturated fat than usual care boys at all follow-up visits. Intervention boys also reported consuming less energy than usual care boys at all follow-up visits, although differences were small and statistically significant only at yr 3 and last visits. Intervention boys consumed significantly more dietary fiber at all follow-up visits than usual care boys.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Characteristics of DISC boys with hormone data

 
Boys in the intervention and usual care groups progressed through puberty in tandem. Age- and race-adjusted mean testicular volume increased from 2 (± 0.05) ml at baseline visits to 22 (± 0.9) ml at last visits and there were no differences between boys in the intervention and usual care groups at any visit (data not shown). Slopes of changes in testicular volume over time also did not differ. Distributions of Tanner stages did not differ between HAS boys in the intervention and usual care groups except at yr 6 visits (data not shown). Results for testicular volume and Tanner stages were comparable when DISC boys not in the HAS were included in analyses.

Serum androgen, estrogen, and SHBG concentrations were similar for intervention and usual care group boys at each visit, and slopes of changes in concentrations over time did not differ by treatment group for any of the hormones measured or for SHBG (Fig. 1Go).


Figure 1
View larger version (20K):
[in this window]
[in a new window]
 
FIG. 1. Serum sex hormone concentrations. Geometric means and 95% confidence intervals at each visit adjusted for age and race are shown in black for the intervention group and gray for the usual care group. (SI conversions: testosterone (nanograms per deciliter) x 34.72 = picomoles per liter; dihydrotestosterone (nanograms per deciliter) x 34.48 = picomoles per liter; androstenedione (nanograms per deciliter) x 34.97 = picomoles per liter; estradiol (nanograms per deciliter) x 36.76 = picomoles per liter; estrone (nanograms per deciliter) x 37.04 = picomoles per liter.)

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
DISC is the first randomized, controlled clinical trial to evaluate the effect of an intervention to reduce fat intake on sexual maturation and serum sex hormone concentrations during adolescence. Boys in the intervention group reported consuming modestly less fat and saturated fat, somewhat less energy, and more fiber, compared with boys in the usual care group. Nonetheless, progression through puberty and serum sex hormone concentrations did not differ by treatment group.

The DISC HAS had several strengths: it was conducted as part of a randomized, controlled clinical trial; 354 boys participated; and blood was collected at several time points. However, DISC participants were selected because they had elevated LDL-C, which could limit generalizability of results. Even so, Caucasian DISC boys were approximately 111/2 yr old at initiation of puberty, which is consistent with most data on sexual maturation of boys in the United States (16) and Europe (17). A high frequency of missing data, particularly at baseline, is a further limitation of our study. However, because the primary reason for missing data at baseline was that most boys were randomized into DISC before initiation of the HAS, missing baseline data decreased study power but would not be expected to bias results. Modest dietary differences further reduced power.

Our findings are consistent with results of the Berkeley Nutrition and Growth Study, which indicate that in an adequately nourished population, diet is not a major determinant of sexual maturation in boys (18). The findings also are consistent with a study by Hebbelinck et al. (19), in which the distribution of Tanner stages in boys who ate a vegetarian diet were in the expected range.

We previously reported significantly lower serum estrogen and progesterone concentrations for girls in the DISC intervention, compared with the usual care group, and concluded that modest reductions in total fat, saturated fat, and possibly energy intake during puberty result in differences in hormone concentrations that suggest altered function of the hypothalamic-pituitary-gonadal axis in girls (6). Gonadal steroidogenesis is regulated by gonadotropins, and pubertal maturation of gonadotropin release before and during puberty has been reported to be gender specific (20). Furthermore, maturation of aromatase activity has been reported to occur later during puberty in males, compared with females (20). Thus, differences in the effect of the DISC intervention on serum sex hormones in boys and girls could reflect underlying physiological differences.

In summary, modest reductions in total fat, saturated fat, and possibly energy intake by nonobese adolescent boys do not alter progression through puberty or serum sex hormone concentrations.


    Acknowledgments
 
The investigators express appreciation to the boys who participated in DISC and their families. The investigators also express appreciation to the NHLBI Project Office, NHLBI (Bethesda, MD): Eva Obarzanek, Ph.D., R.D. (project officer); Jeffrey A. Cutler, M.D.; Marguerite A. Evans, M.S., R.D.; Sally A. Hunsberger, Ph.D.; Denise G. Simons-Morton, M.D., Ph.D.; and the DISC Data and Safety Monitoring Committee: John C. LaRosa, M.D. (chair); Phyllis E. Bowen, Ph.D.; Allan Drash, M.D.; Robert J. Hardy, Ph.D.; Judith K. Ockene, Ph.D.; Carol Whalen, Ph.D.; Richard H. Grimm, M.D., Ph.D.; and Melvin M. Grumbach, M.D. (ad hoc member).


    Footnotes
 
This work was supported in part by Cooperative Agreements U01-HL37947, U01-HL37948, U01-HL37954, U01-HL37962, U01-HL37966, U01-HL37975, and U01-HL38110 from the National Heart, Lung, and Blood Institute supplemented by the National Cancer Institute, National Institutes of Health.

Disclosures: J.F.D., R.P.M., L.A.F., L.V.H., L.G.S., P.O.K., R.M.L., N.L.L., V.J.S., A.R., S.F.C., F.A.F., B.A.B., B.H.P., P.R.T., and A.S. have nothing to declare. D.W.C. is employed by and previously held equity interests in Esoterix Endocrinology, Inc. At the time the assays were conducted, D.W.C. held stock in Esoterix Endocrinology, Inc. (Calabasas Hills, CA). None of the other authors has any conflicts of interest.

First Published Online July 25, 2006

Abbreviations: DISC, Dietary Intervention Study in Children; HAS, Hormone Ancillary Study; LDL-C, low-density lipoprotein cholesterol.

Received January 19, 2006.

Accepted July 18, 2006.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L, Taylor PR 1996 Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr 64:850–855[Abstract/Free Full Text]
  2. Reed MJ, Cheng RW, Simmonds M, Richmond W, James VH 1987 Dietary lipids: an additional regulator of plasma levels of sex hormone binding globulin. J Clin Endocrinol Metab 64:1083–1085[Abstract/Free Full Text]
  3. Hamalainen E, Adlercreutz H, Puska P, Pietinen P 1984 Diet and serum sex hormones in healthy men. J Steroid Biochem 20:459–464[CrossRef][Medline]
  4. Wang C, Catlin DH, Starcevic B, Heber D, Ambler C, Berman N, Lucas G, Leung A, Schramm K, Lee PW, Hull L, Swerdloff RS 2005 Low-fat high-fiber diet decreased serum and urine androgens in men. J Clin Endocrinol Metab 90:3550–3559[Abstract/Free Full Text]
  5. Wu AH, Pike MC, Stram DO 1999 Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91:529–534[Abstract/Free Full Text]
  6. Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich Jr PO, Lauer RM, Van Horn L, Lasser NL, Stevens VJ, Friedman LA, Yanovski JA, Greenhut SF, Chandler DW, Franklin FA, Barton BA, Buckman DW, Snetselaar LG, Patterson BH, Schatzkin A, Taylor PR 2003 Diet and sex hormones in girls: findings from a randomized controlled clinical trial. J Natl Cancer Inst 95:132–141[Abstract/Free Full Text]
  7. DISC Collaborative Research Group 1993 Dietary intervention study in children (DISC) with elevated low-density-lipoprotein cholesterol. Design and baseline characteristics. Ann Epidemiol 3:393–402[Medline]
  8. The Writing Group for the DISC Collaborative Research Group 1995 Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). JAMA 273:1429–1435[Abstract/Free Full Text]
  9. Obarzanek E, Kimm SY, Barton BA, Van Horn LL, Kwiterovich Jr PO, Simons-Morton DG, Hunsberger SA, Lasser NL, Robson AM, Franklin Jr FA, Lauer RM, Stevens VJ, Friedman LA, Dorgan JF, Greenlick MR 2001 Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics 107:256–264[Abstract/Free Full Text]
  10. Hartmuller VW, Snetselaar L, Van Horn L, Steinmuller P, Smith K, Gernhofer N 1994 Creative approaches to cholesterol lowering used in the dietary intervention study in children. Top Clin Nutr 10:71–78
  11. Stevens VJ, Obarzanek E, Franklin FA, Steinmuller P, Snetselaar L, Lavigne J 1995 Dietary Intervention Study in Children (DISC): intervention design and participation. J Nutr Educ 27:133–140
  12. Van Horn LV, Gernhofer N, Moag-Stahlberg A, Farris R, Hartmuller G, Lasser VI, Stumbo P, Craddick S, Ballew C 1990 Dietary assessment in children using electronic methods: telephones and tape recorders. J Am Diet Assoc 90:412–416[Medline]
  13. Van Horn LV, Stumbo P, Moag-Stahlberg A, Obarzanek E, Hartmuller VW, Farris RP, Kimm SY, Frederick M, Snetselaar L, Liu K 1993 The Dietary Intervention Study in Children (DISC): dietary assessment methods for 8- to 10-year-olds. J Am Diet Assoc 93:1396–1403[CrossRef][Medline]
  14. Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH, Greenhut SF 2002 Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 67:151–158[CrossRef][Medline]
  15. Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Tejpar AA, Clevidence BA, Giffen CA, Chandler DW, Stanczyk FZ, Taylor PR 2001 Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 93:710–715[Abstract/Free Full Text]
  16. Lee PA, Guo SS, Kulin HE 2001 Age of puberty: data from the United States of America. APMIS 109:81–88[CrossRef][Medline]
  17. de Muinich Keizer SM, Mul D 2001 Trends in pubertal development in Europe. Hum Reprod Update 7:287–291[Abstract/Free Full Text]
  18. Mills JL, Shiono PH, Shapiro LR, Crawford PB, Rhoads GG 1986 Early growth predicts timing of puberty in boys: results of a 14-year nutrition and growth study. J Pediatr 109:543–547[CrossRef][Medline]
  19. Hebbelinck M, Clarys P, De Malsche A 1999 Growth, development, and physical fitness of Flemish vegetarian children, adolescents, and young adults. Am J Clin Nutr 70:579S–585S
  20. Potau N, Ibanez L, Sentis M, Carrascosa A 1999 Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge. Eur J Endocrinol 141:27–34[Abstract]



This article has been cited by other articles:


Home page
Am J EpidemiolHome page
C. M. Schooling, C. Q. Jiang, T. H. Lam, W. S. Zhang, K. K. Cheng, and G. M. Leung
Life-Course Origins of Social Inequalities in Metabolic Risk in the Population of a Developing Country
Am. J. Epidemiol., February 15, 2008; 167(4): 419 - 428.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorgan, J. F.
Right arrow Articles by Schatzkin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorgan, J. F.
Right arrow Articles by Schatzkin, A.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Male Endocrinology
Right arrow Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals